← Leaderboards
Javier A. Neyra
University Of Kentucky
$4,703,171
Attributed
$8,076,482
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2020–25$5M$3.8M$2.5M$1.3M$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,076,482 · 6
By mechanism
R01$3,549,180 · 2
U01$3,097,442 · 1
U54$1,329,860 · 2
R56$100,000 · 1
Top collaborators
- David Alan Drew5 shared
- Girish Nitin Nadkarni4 shared
- Edward D Siew4 shared
Most similar at University Of Kentucky
Same institution · by research overlap
- Ming C Gong$10,288,417
- Zhenheng Guo$9,758,888
Others in their field
Other Emerging Leaders on “Kidney”
- Xinhua Li · Nano Terra, Inc.$32,520,955
- Chani Eduard · Precision Bioservices, Inc.$19,909,203
- Robyn Lorraine Woods · Hennepin Healthcare Research Institute$19,109,927
- Barbara Halina Braffett · George Washington University$18,816,779
- Ionut Bebu · George Washington University$18,816,779
- Noel P Burtt · Broad Institute, Inc.$12,561,765
Research focus
KidneyRisk FactorsClinical ResearchInnovationElectronic Health RecordAcute Renal Failure With Renal Papillary NecrosisMortalityAffectRecoveryKidney DiseasesPersonsClinical DataReproducibilityInstitutionTranslational ResearchFutureResponseValidationCaringPre-ClinicalInfrastructureEventPhenotypeCessation Of Life
Grant awards (19)
The Southeastern Acute Kidney Injury (SEAK) Alliance for the COPE-AKI Consortium$1,152,935
U01 · FY2025 · DK
Artificial Intelligence to Predict Outcomes in Patients with Acute Kidney Injury on Continuous Renal Replacement Therapy$609,234
R01 · FY2025 · DK · contact PI
The Relation of Soluble Klotho with Cardiovascular Disease, Chronic Kidney Disease Progression, and Blood Pressure in the Systolic Blood Pressure Intervention Trial$301,530
R01 · FY2025 · DK
Clinical Core$292,674
U54 · FY2025 · DK · contact PI
Resource Development Core$146,434
U54 · FY2025 · DK · contact PI
Artificial Intelligence to Predict Outcomes in Patients with Acute Kidney Injury on Continuous Renal Replacement Therapy$639,420
R01 · FY2024 · DK · contact PI
The Southeastern Acute Kidney Injury (SEAK) Alliance for the COPE-AKI Consortium$630,256
U01 · FY2024 · DK
Clinical Core$292,819
U54 · FY2024 · DK · contact PI
The Relation of Soluble Klotho with Cardiovascular Disease, Chronic Kidney Disease Progression, and Blood Pressure in the Systolic Blood Pressure Intervention Trial$289,468
R01 · FY2024 · DK
Resource Development Core$146,418
U54 · FY2024 · DK · contact PI
Artificial Intelligence to Predict Outcomes in Patients with Acute Kidney Injury on Continuous Renal Replacement Therapy$705,025
R01 · FY2023 · DK · contact PI
The Southeastern Acute Kidney Injury (SEAK) Alliance for the COPE-AKI Consortium$647,584
U01 · FY2023 · DK
Clinical Core$305,051
U54 · FY2023 · DK · contact PI
The Relation of Soluble Klotho with Cardiovascular Disease, Chronic Kidney Disease Progression, and Blood Pressure in the Systolic Blood Pressure Intervention Trial$277,902
R01 · FY2023 · DK
Resource Development Core$146,464
U54 · FY2023 · DK · contact PI
The Southeastern Acute Kidney Injury (SEAK) Alliance for the COPE-AKI Consortium$666,667
U01 · FY2022 · DK
The Relation of Soluble Klotho with Cardiovascular Disease, Chronic Kidney Disease Progression, and Blood Pressure in the Systolic Blood Pressure Intervention Trial$298,859
R01 · FY2022 · DK
The Relation of Soluble Klotho with Cardiovascular Disease, Chronic Kidney Disease Progression, and Blood Pressure in the Systolic Blood Pressure Intervention Trial$427,742
R01 · FY2021 · DK
Artificial Intelligence to Predict Outcomes in Patients with Acute Kidney Injury on Continuous Renal Replacement Therapy$100,000
R56 · FY2020 · DK · contact PI